Louise Flanagan

Louise Wood Flanagan (born June 26, 1962) is a United States district judge of the United States District Court for the Eastern District of North Carolina. Provided by Wikipedia
Showing 1 - 7 results of 7 for search 'Louise Flanagan', query time: 0.03s Refine Results
  1. 1
    The Case for a More Holistic Approach to Dry Eye Disease: Is It Time to Move beyond Antibiotics?

    The Case for a More Holistic Approach to Dry Eye Disease: Is It Time to Move beyond Antibiotics? by Azadeh Tavakoli, Judith Louise Flanagan

    Published 2019-06-01
    Get full text
    Article
  2. 2
    Targeting regulatory T cells to improve vaccine immunogenicity in early life

    Targeting regulatory T cells to improve vaccine immunogenicity in early life by Jorjoh eNdure, Katie Louise Flanagan

    Published 2014-09-01
    Get full text
    Article
  3. 3
    Readmission to hospital following laparoscopic cholecystectomy: a meta-analysis

    Readmission to hospital following laparoscopic cholecystectomy: a meta-analysis by Caroline McIntyre, Alison Johnston, Deirdre Foley, Jack Lawler, Magda Bucholc, Louise Flanagan, Michael Sugrue

    Published 2020-02-01
    Get full text
    Article
  4. 4
    CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases (CARBON): study protocol for a phase IB/IIA randomised controlled trial

    CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases (CARBON): study protocol for a phase IB/IIA randomised controlled trial by Rob Coleman, Janet Brown, Emma Rathbone, Louise Flanagan, Amber Reid, Jessica Kendall, Sacha Howell, Chris Twelves, Carlo Palmieri, Anjana Anand, Iain MacPherson, Sarah Brown

    Published 2020-01-01
    Get full text
    Article
  5. 5
    Investigating the potential clinical benefit of Selumetinib in resensitising advanced iodine refractory differentiated thyroid cancer to radioiodine therapy (SEL-I-METRY): protocol for a multicentre UK single arm phase II trial

    Investigating the potential clinical benefit of Selumetinib in resensitising advanced iodine refractory differentiated thyroid cancer to radioiodine therapy (SEL-I-METRY): protocol... by Sarah R. Brown, Andrew Hall, Hannah L. Buckley, Louise Flanagan, David Gonzalez de Castro, Kate Farnell, Laura Moss, Rebecca Gregory, Kate Newbold, Yong Du, Glenn Flux, Jonathan Wadsley

    Published 2019-06-01
    Get full text
    Article
  6. 6
    Combining TNFR2-Expressing Tregs and IL-6 as Superior Diagnostic Biomarkers for High-Grade Serous Ovarian Cancer Masses

    Combining TNFR2-Expressing Tregs and IL-6 as Superior Diagnostic Biomarkers for High-Grade Serous Ovarian Cancer Masses by Nirmala Chandralega Kampan, Apriliana Ellya Ratna Kartikasari, Cyril Deceneux, Mutsa Tatenda Madondo, Orla M. McNally, Katie Louise Flanagan, Norhaslinda A. Aziz, Andrew N. Stephens, John Reynolds, Michael A. Quinn, Magdalena Plebanski

    Published 2023-01-01
    Get full text
    Article
  7. 7
    PRISM protocol: a randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced or metastatic renal cell carcinoma

    PRISM protocol: a randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced or metastatic rena... by Hannah L. Buckley, Fiona J. Collinson, Gemma Ainsworth, Heather Poad, Louise Flanagan, Eszter Katona, Helen C. Howard, Geraldine Murden, Rosamonde E. Banks, Joanne Brown, Galina Velikova, Tom Waddell, Kate Fife, Paul D. Nathan, James Larkin, Thomas Powles, Sarah R. Brown, Naveen S. Vasudev

    Published 2019-11-01
    Get full text
    Article

Search Tools: